Publication | Closed Access

Treatment with a GLP−1R agonist over four weeks promotes weight loss-moderated changes in frontal-striatal brain structures in individuals with mood disorders

Glp−1r AgonistFrontal-striatal Brain StructuresPsychiatryPsychopharmacologyDepressionNeuropharmacologySocial SciencesNeuroscienceMood DisordersNeurologyDopamineMedicinePsychopathology